Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KraneShares is a global asset management firm specializing in exchange-traded funds (ETFs) and investment strategies that target China's capital markets, climate change, and disruptive technologies. The firm is recognized for its thematic approach, offering products like the KraneShares CSI China Internet ETF (KWEB) and the KraneShares MSCI All China Health Care Index ETF (KURE), which provides exposure to the Chinese healthcare ecosystem. KraneShares provides institutional and individual investors with research-driven access to emerging growth themes and diversification opportunities. Headquartered in New York with offices in London and San Francisco, the company was founded in 2011 and is majority-owned by China International Capital Corporation (CICC).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KraneShares.